The Holy Cross Health Institutional Review Board (IRB) is comprised of highly qualified members with significant experience and knowledge in the scientific, legal and ethical aspects of clinical trials. The mission of the IRB is to protect the rights and welfare of human research subjects.
We operate under all applicable federal and state regulations, including the Food and Drug Administration (FDA), and the guidance of the Office of Human Research Protection (OHRP). Holy Cross Health IRB abides by the International Committee on Harmonization (ICH) guidelines and Good Clinical Practice (GCP) guidelines.
For more information, contact Bonnie Buggs-Perow, BS, IRB Coordinator at 301-754-7795 or email@example.com